drug class

Peptide bioregulator

short peptides developed in Russia and claimed to regulate gene expression in a specific organ; the evidence is mostly from the developers' own cell and animal studies.

1 compound · filter the full catalogue by this class

CartalaxPeptide
Cartalax is the tripeptide Ala-Glu-Asp (AED), one of the short "peptide bioregulators" developed by Vladimir Khavinson's group in St Petersburg and promoted for cartilage. In cell cultures it switched on cartilage-forming genes in ageing human stem cells and lowered markers of ageing in chondrocytes. There are no published human trials, and almost every study comes from the developers' own group.
Preclinical